LIENNasdaqUS GAAP · USD

Chicago Atlantic BDC, Inc.

Chicago Atlantic BDC, Inc. is a Maryland-based externally managed business development company that provides specialty financing to companies in highly regulated and complex industries. Its core focus is direct lending to cannabis businesses, with additional investments in growth and technology, esoteric lending, and liquidity solutions where traditional lenders are often absent.

Net income33.3m USD
+245.8 %y/y

Fiscal year 2025 · change from previous year

Development 2022–2025

01m USD2022202320242025
RevenueOperating profit (EBIT)
Ask Clarifo about Chicago Atlantic BDC, Inc.

Business

Share of revenue
Cannabis direct lending60 %

Loans and structured credit to cannabis operators across the ecosystem, typically in underserved markets.

Growth & technology lending15 %

Financing for software, hardware, e-commerce, and other fast-growing companies with strong growth trajectories.

Esoteric & asset-based lending15 %

Specialty credit backed by less conventional assets or complex structures where underwriting is highly bespoke.

Liquidity solutions10 %

Capital solutions for companies needing funding without equity dilution, often in complex or transitional situations.

Customers

The company lends to privately held cannabis operators that need capital but want to avoid equity dilution, and that often have cash flow, leverage, and covenant profiles suitable for structured credit. It also targets growth-oriented businesses and other specialty borrowers that are underserved by banks and traditional direct lenders. Borrowers are typically seeking non-dilutive capital, flexible structures, and financing tailored to industry complexity.

Cannabis companies

Privately held cannabis operators that need direct loans, structured covenants, and capital without issuing more equity.

Growth & technology companies

Software, hardware, e-commerce, and direct-to-consumer businesses seeking growth capital and liquidity runway.

Esoteric asset-based borrowers

Companies with non-traditional collateral or complex financing needs that require bespoke underwriting.

Liquidity solution borrowers

Businesses needing capital to bridge timing gaps, refinance obligations, or support operations without dilution.

Strategy

The company is focused on originating senior secured, covenant-protected loans in cannabis and other underserved specialty credit markets. It is also broadening into growth and technology and other esoteric lending opportunities to diversify originations while staying in areas where underwriting complexity can support attractive pricing and terms.

Maintain focus on cannabis direct lendingShort term

This is the core niche where the adviser believes pricing and covenants are most attractive due to industry complexity.

Grow non-cannabis specialty lendingMedium term

Adding growth and technology or asset-based opportunities can diversify the portfolio and reduce concentration risk.

Preserve credit quality and downside protection

Senior secured structures, low leverage, and liquidity covenants are intended to protect capital in stressed industries.

Geography

The portfolio is primarily U.S.-based, with headquarters concentration across the Midwest, West, Northeast, Southeast, and Southwest. The company also has a small Canada exposure, but its business is overwhelmingly tied to U.S. borrowers and U.S. state-level regulatory environments, especially in cannabis.

Risks

The main company-specific risk is credit exposure to cannabis borrowers, where regulation, banking access, and operating volatility can impair repayment capacity. The company also uses leverage and a secured revolving credit facility, which increases refinancing and asset-encumbrance risk if portfolio performance weakens. As a BDC, it is also exposed to fair value volatility in private investments and to underwriting risk in other specialty lending verticals.

Sorted by severity
Leverage and credit facility riskHigh

The revolving credit agreement can place security interests on assets and create foreclosure risk if covenants or repayments are missed.

Exposure: Company-level financing

Cannabis industry regulatory riskHigh

Borrowers operate in a highly regulated market where legal changes, licensing issues, or banking constraints can affect cash flow and loan performance.

Exposure: Primary portfolio focus

Fair value volatility on private investmentsMedium

Most holdings are illiquid and valued using management judgment and third-party inputs, so marks can change materially with borrower performance.

Exposure: Investment portfolio

Concentration in underserved specialty creditMedium

The strategy depends on niche markets where underwriting is bespoke and borrower quality can vary widely.

Exposure: Portfolio construction

Accounting

Judgemental items
Fair value measurement of private loans and equity

Most portfolio assets are illiquid and require good-faith valuation, which can materially affect NAV and earnings.

Impact: Net asset value and unrealized gains/losses

Effective yield and prepayment accounting

Loan accretion, discounts, and prepayments change reported interest income over time.

Impact: Interest income and periodic earnings

RIC tax qualification and distribution requirements

Maintaining RIC status requires income and asset tests plus distributions, which affect capital retention and payout capacity.

Impact: Tax expense and dividend policy

Investment company accounting under Topic 946

The company reports as an investment company, so portfolio marks and realized/unrealized results are central to the statements.

Impact: Income statement presentation and NAV

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026

Chicago Atlantic BDC, Inc. (LIEN) Revenue, Earnings & Financials 2025 – Clarifo